Higher Sclerostin/SOST expression is associated with lower percentage of circulatory blasts and better prognosis in patients with myelofibrosis.
Marko LucijanicAna LivunKatarina Marija TupekTajana Stoos-VeicVlatko PejsaRajko KusecPublished in: Annals of hematology (2018)